ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report심장 이식 환자의 난치성 중증 COVID-19 폐렴을 치료하기 위해 부분적으로 HLA와 일치하는 기성품인 SARS-CoV-2-특이적 T 세포 요법인 ALVR109: 사례 보고Case Reports Published on 2022-04-012022-09-11 Journal: American journal of transplantation : official jou [Category] [DOI] 10.1111/ajt.16927 PMC 바로가기 [Article Type] Case Reports
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectivesReview Published on 2022-03-242023-06-14 Journal: Stem Cell Research & Therapy [Category] [DOI] 10.1186/s13287-022-02810-6 PMC 바로가기 [Article Type] Review
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trialClinical Trial Published on 2022-03-212022-10-05 Journal: Stem Cell Research & Therapy [Category] [DOI] 10.1186/s13287-022-02796-1 PMC 바로가기 [Article Type] Clinical Trial
SARS-CoV-2 Infection and Lung RegenerationReview Published on 2022-02-022023-06-15 Journal: Clinical microbiology reviews [Category] [DOI] 10.1128/cmr.00188-21 PMC 바로가기 [Article Type] Review
Online seminars as an information source for direct-to-consumer stem cell therapyArticle Published on 2022-02-012023-07-07 Journal: Regenerative Medicine [Category] [DOI] 10.2217/rme-2021-0070 PMC 바로가기
Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injuryCOVID-19 급성 폐 손상과 관련된 염증성 사이토카인에 대한 다양한 치료 세포 유형 감수성의 직접 비교Research Published on 2022-01-152022-09-10 Journal: Stem Cell Research & Therapy [Category] [DOI] 10.1186/s13287-021-02699-7 PMC 바로가기 [Article Type] Research
Potential therapeutic options for COVID-19: an update on current evidenceCOVID-19에 대한 잠재적인 치료 옵션: 현재 증거에 대한 업데이트Review Published on 2022-01-132022-09-11 Journal: European Journal of Medical Research [Category] [DOI] 10.1186/s40001-021-00626-3 PMC 바로가기 [Article Type] Review
Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue RegenerationImmunology Published on 2022-01-132022-11-01 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2021.780900 PMC 바로가기 [Article Type] Immunology
Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challengesReviews Published on 2021-12-312022-10-30 Journal: Intensive Care Medicine Experimental [Category] [DOI] 10.1186/s40635-021-00424-5 PMC 바로가기 [Article Type] Reviews
Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19Cell and Developmental Biology Published on 2021-12-142022-10-31 Journal: Frontiers in Cell and Developmental Biology [Category] [DOI] 10.3389/fcell.2021.813384 PMC 바로가기 [Article Type] Cell and Developmental Biology